ImmunityBio
IBRX
IBRX
180 hedge funds and large institutions have $256M invested in ImmunityBio in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 41 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
180
Holders Change
-11
Holders Change %
-5.76%
% of All Funds
2.6%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
63
Reduced
41
Closed
31
Calls
$18.7M
Puts
$10.9M
Net Calls
+$7.77M
Net Calls Change
+$18.9M
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$62.9M |
| 2 |
2
Morgan Stanley
New York
|
$8.36M |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$7.7M |
| 4 |
4
Millennium Management
New York
|
$4.15M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$32.2M |
